Navigation Links
OvaGene Oncology Opens New Innovative Gynecologic Cancer Laboratory and Research Facility
Date:6/22/2010

IRVINE, Calif., June 22 /PRNewswire/ -- OvaGene Oncology Inc., a biotechnology company specializing in the development and commercialization of personalized DNA-based diagnostics for gynecologic cancer, announced today the opening of its new clinical and research laboratory in Irvine, California.  This state-of-the-art facility will serve as the central headquarters for operations, research, and molecular clinical lab testing.  

The opening of the laboratory is an important first step for OvaGene Oncology.  The new facility will allow the company to perform genomic testing on cancer cells using advanced technologies such as Quantitative Polymerase Chain Reaction (QPCR), Comparative Genomic Hybridization (CGH) and Gene Expression Arrays. OvaGene is currently in the process of pursuing clinical laboratory licensure (CLIA) and accreditation (CAP) and will begin offering several non-proprietary molecular diagnostics to the gynecologic oncology community once approvals have been obtained.  

In addition to clinical laboratory testing, a series of proprietary diagnostics based on in-licensed technologies and internal research will be developed at the new facility. OvaGene's research will include collaborations with key pharmaceutical companies in the oncology space with the goal of developing companion diagnostics.  

"This advanced molecular research and clinical laboratory facility is the foundation for OvaGene's creativity, science and treatment-related innovation. It puts OvaGene at the forefront of the application of gene-based technologies within the field of gynecologic oncology," said President and CEO Frank Kiesner.  Mr. Kiesner added, "It is OvaGene's mission to provide physicians treating gynecologic cancers with novel gene-based assays to individualize patient diagnosis, staging and drug selection in a manner not possible through existing non-gene-based technologies."

About OvaGene Oncology

OvaGene Oncology is a molecular diagnostics company, located in Orange County, California, dedicated to improving cancer care and outcomes for gynecologic cancer patients through the development of novel gene-based assays.  The company plans to offer proprietary and non-proprietary molecular diagnostic assays to assist physicians in the prognosis of gynecologic cancers as well as therapy selection, including radiation and chemotherapy.  There are over 11,000 cases of cervical cancer, 25,000 cases of ovarian cancer and 42,000 cases of endometrial cancer diagnosed each year in the United States.  The total market for OvaGene's genomic assays is over 80,000 gynecologic cancer cases diagnosed annually. Please visit our website at www.ovagene.com for more information about our company.


'/>"/>
SOURCE OvaGene Oncology Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Varian Medical Systems Equips International Oncologys First Comprehensive Cancer Center in India
2. Boehringer Ingelheim Affirms Safety of Telmisartan With an Analysis of 50,000 Patients and Strongly Disagrees With the Publication of Sipahi et al in Lancet Oncology June 2010
3. Genomic Health Announces Results From the Largest Genomic Analysis of Localized Clear Cell Renal Carcinoma at American Society of Clinical Oncology (ASCO) Annual Meeting
4. Abbott to Present Data on Several Investigational Cancer Treatments at American Society of Clinical Oncology Annual Meeting
5. US Oncology Announces iKnowMed(TM) Technology Platform
6. Elekta Impac Software to Demonstrate Oncology EHR Capabilities at Electronic Health Records Lab in Chicago
7. Onyx Pharmaceuticals Announces Carfilzomib Data Presentations at 46th American Society of Clinical Oncology Annual Meeting
8. Delcath Reconfirms Presentation During American Society of Clinical Oncology 2010 Annual Meeting in Chicago
9. Southwest Oncology Network (SWON) Selects Diplomat Specialty Pharmacy for Development and Launch of SWON-Rx, an Oral Oncology Medication Management Platform
10. US Oncology Launches New Flexible Options for Community Oncologists to Join the United Network of US Oncology
11. US Oncology Meets With Leading Pharmaceutical and Biotech Companies to Design Clinical Trials for the Cancer Fighting Drugs of Tomorrow
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/14/2017)... Calif. , June 14, 2017 The ... the City of Fremont and ... of the bio-pharma industry in California ... technology, enabling executive networking, and fostering workforce development. The ... development and growth of start-ups, as well as small ...
(Date:6/12/2017)... , June 12, 2017 Kineta, Inc., a ... announced Kineta Vice President of R&D and Head ... the Pandemic Preparedness for the Northwest and Beyond ... held on June 14, 2017 from 8:30-10:30 AM PDT at ... Dr. Bedard will be joined by ...
(Date:6/9/2017)... AirXpanders, Inc. (ASX: AXP) (AirXpanders or Company), ... sale and distribution of the AeroForm® Tissue Expander System, ... commercial roll-out in the United States ... hundred (100) medical institutions and health systems, located throughout ... alternative for women who choose reconstructive surgery following a ...
Breaking Medicine Technology:
(Date:6/23/2017)... ... June 23, 2017 , ... ... and related services to families and business owners in and around Lackawanna County, ... benefit senior citizens in the area. , Meals on Wheels of NEPA provides ...
(Date:6/22/2017)... ... June 22, 2017 , ... Branches, Inc. has been partnering with ... grant funding to support its programs focused on providing opportunity to low-income families and ... grant by the Foundation of $15,000 to support its , Climb to College & ...
(Date:6/22/2017)... ... June 23, 2017 , ... Despite its pervasiveness, many physicians are unfamiliar ... integrate basic science with clinical practice. Now, however, a timely review has been published ... insight into the etiology of NeuP and educating preclinical scientists on its diagnosis and ...
(Date:6/20/2017)... , ... June 20, 2017 , ... ... announced today that Claritas Capital, a Nashville-based private equity firm, has invested $3.35 ... expansion plans for some time, and Claritas Capital offers the smart money, speed ...
(Date:6/20/2017)... ... June 20, 2017 , ... Hayes, ... published a new eBook titled “ 5 Questions to Ask Before Entering the ... on the Genetic Test Evaluation (GTE) team, the book explores the various types ...
Breaking Medicine News(10 mins):